Recent works suggest that lncRNA-ATB functions as ceRNA also for miR-141-3p, a direct binder and inhibitor of ZEB1 and ZEB2, in breast and gastric cancer [42,43] and that its expression correlates to trastuzumab resistance in HER2-positive breast cancer cells [46]. Here, ZEB1 is linked to gastric cancer.